video
Steven Feldman, MD, PhD, of Wake Forest School of Medicine, typically wouldn't have his psoriasis patients discontinue biologics prior to surgery. Here's why. (1:11)
A new systematic review and meta-analysis provides more-detailed information on the greater risk for hypertension and cardiovascular events among patients with inflammatory autoimmune diseases.
A cross-sectional study compared work productivity in patients with inflammatory bowel disease, Crohn’s disease, psoriasis, and psoriatic arthritis/spondyloarthritis and found that even patients in remission or with mild disease activity report some burden of presenteeism, work productivity loss, or activity impairment.
video
Steven Feldman, MD, PhD, of Wake Forest School of Medicine, doesn't wait when switching between biologics in his psoriasis patients. Here's why. (1:00)
A comparison of patients with PsO and PsA identified several possible predictors for the progression from PsO to PsA, and examined whether MRI scans improved prediction of PsA.
South Korean researchers found that adult patients who have failed a prior biologic therapy for their psoriasis perceive their quality of life to be significantly lower than those who had not.
Investigators conducted a population-based study to determine the role of vitamin D deficiency in psoriasis and how body mass index might mediate the relationship.